Home
About Us
Research Projects
Research Staff
Career Opportunities
Contact Us
Employee Advisories
Research Staff
Heidi Krause-Steinrauf, M.S.
Heidi Krause-Steinrauf, M.S., Lead Research Scientist, joined the Biostatistics Center in 2002 as Co-Investigator and Deputy Director of Protocols for the Type 1 Diabetes TrialNet Network, sponsored by NIDDK. She is currently the Co-Investigator and Project Director for the Glycemia Reduction Approaches in Type 2 Diabetes (GRADE) Study, a comparative effectiveness trial funded by NIDDK. Prior to joining the Biostatistics Center in 2002, she served as a Clinical Trials Scientific Programs Specialist/Project Officer in the NHLBI Clinical Trials Scientific Research group, Division of Epidemiology and Clinical Applications, where she was involved in the development of new research initiatives, collaborated in the development of manuscripts and research oversight. From 1995-2000, she served as the Study Biostatistician for the Beta-Blocker Evaluation of Survival Trial (BEST) co-sponsored by the NIH/NHLBI and Veterans Affairs Cooperative Studies Program (VA CSP), and Co-Principal Investigator and Co-Chair of the Genetic Tissue Banking Initiative for clinical trials. Ms. Krause-Steinrauf was a biostatistician at the Biostatistics Center from 1991-1994 for NIH sponsored studies conducted through the NICHD Neonatal Research Network, the Randomized Clinical Trial of Dexamethasone Therapy in Very Low Birth Weight (VLBW) infants at Risk for Chronic Lung Disease, and Maternal Lifestyles Study. Prior to this she was a biostatistician at the VA CSP Coordinating Center in Palo Alto, California, for the Stroke Prevention in Atrial Fibrillation (SPINAF) Trial. She is the co-author of over 30 papers on the design, methods, analysis and conclusions of studies with which she has been involved. Her interests include data and safety monitoring and application of new technologies for efficient management of clinical trials. She serves as an ad hoc grant reviewer for NIH and the Department of Veterans Affairs and has served on data and safety monitoring boards for trials in diabetes and cardiovascular disease. Ms. Krause-Steinrauf has been elected a fellow of the Society for Clinical Trials.